26/42 Are there any national datasets that accurately capture what is going on? The brilliant @jburnmurdoch has highlighted number of admissions into ICU. The message from his animated chart (click on link) couldn’t be clearer – this winter is v unusual: https://t.co/76ZvHU2pmV.
NEW: a common response to reports of hospitals struggling this winter is "it\u2019s no different to a bad flu season!"
— John Burn-Murdoch (@jburnmurdoch) January 7, 2021
I\u2019ve tracked down historical data on flu ICU admissions, including winter 2017-18, a record high.
Here\u2019s how England\u2019s Covid winter compares to a bad flu season \U0001f4f9 pic.twitter.com/tsExrDZM31
Here's a detailed thread explaining how the weekly ONS data should be interpreted when monitoring all cause mortality and excess deaths. It seems very common for people to misinterpret the data relating to excess deaths so I will do my best to clarify in a series of tweets. 1/10 pic.twitter.com/r2TUH7I4wE
— Michael George (@Mike_aka_Logiqx) January 9, 2021
To believe the hypothesis posed by the sceptics you also have to believe this. Either those charged with monitoring the nation\u2019s health \u2013 the CMO, CSA, their colleagues in the regions, Ministers, officials \u2013 are unaware of the data flaws Julia and her allies have identified...
— (((Dan Hodges))) (@DPJHodges) January 8, 2021
More from Health
There have been many so-called experts on the idiotbox opining about apparent availability of P III data which 1/n
2/n apparently the SEC had access to based on which it "supposedly" approved Covaxin. Another argument that is prevalent is other regulators (US FDA and MHRA) also approved vaccines based on P II data alone. Let me give you a few facts so that you can make your own decision.
3/n The protocols for both mRNA vaccines are publicly available. You can check. Both protocols *define* when the interim analysis will be done. This is not subjective. They clearly define how many infections need to be documented before the Data Safety Monitoring Board meets.
4/n Find the protocols for the bridging study for CovidShield and Covaxin and look for a similar milestone.
Here is one set of efficacy data post the interim analysis of a mRNA vaccine.
Source: https://t.co/BAPnP3PxEb
5/n This data was analyzed post the interim analysis where the blind was broken by the DSMB. Now ask yourself this question:
How does the SEC, or the sponsor of these studies, or the experts who are offering their opinion liberally on the idiotbox know what the efficacy is
A very big welcome to everyone joining today’s conversation. Our guest today needs no introduction especially in the sphere of cancer control and advocacy. Welcome @runciecwc
#CheatCervicalCancer
Our First guest is Runcie Chidebe @runciecwc.
— Smile With Me (#CheatCervicalCancer) (@SMILEWithmeNGO) January 31, 2021
He is a patient advocate and global health expert. He is the ED of @projectpinkblue, a cancer nonprofit focused on cancer control in Nigeria. He is engaged in supporting people battling with cancer, fundraising for indigent patients, pic.twitter.com/6tKYkq4h4F
@runciecwc Q1: So Runcie @runciecwc, we see all the amazing work you do as an advocate.
Can you share with us some of the work that you have been doing in cancer control in Nigeria?
#CheatCervicalCancer
@runciecwc That’s amazing. Your work speaks for you. Thanks for all you do.
Q2: What is this @WHO Global Strategy to accelerate the Elimination of CervicalCancer? Can you elaborate on it?
#CheatCervicalCancer
@runciecwc @WHO Q3: In your experience, so far what are the greatest challenges you have identified with cancer control in Nigeria?
#CheatCervicalCancer.
@runciecwc @WHO Q4: Interestingly, we have seen that your organization is part of the Coalition of CSOs against Cervical Cancer in Nigeria, @CervicalCancerN, what is the goal of this Coalition? #CheatCervicalCancer